Tagged with Pharmaceutical Research and Manufacturers of America

Samir Khalil – Executive Director, PhRMA Middle East & Africa

Middle East & Africa Samir Khalil – Executive Director, PhRMA Middle East & Africa

Middle East & Africa Samir Khalil, executive director for the Pharmaceutical Research and Manufacturers of America (PhRMA) Middle East and Africa, touts the USD 1.1 trillion that its member companies have invested in R&D since 2000 and analyses the opportunities in Egypt as the country moves closer to implementing universal healthcare. In addition, he…

Heated Dispute Over Drug Pricing in New Inflation Reduction Act

USA Heated Dispute Over Drug Pricing in New Inflation Reduction Act

USA While patient groups view the United States’ new Inflation Reduction Act as a positive move towards capping out-of-pocket drug costs for older Americans, the innovative pharma industry, after aggressively lobbying against it, still argues that the new legislation will hamper drug development. [The new law] is a significant step in…

US Abortion Ruling Pharma Industry Response

USA US Abortion Ruling Pharma Industry Response

USA Pharma companies have become vocal about social issues in recent years, championing access and affordability and launching initiatives to address diversity, but in the weeks since the United States’ Supreme Court’s overturn of the Roe v. Wade ruling on abortion the industry’s reaction has been far from consistent. While certain…

Other Topics

India

M&A

European Biotech

Cell & Gene Therapy

R&D Section Page